Federal contract award
72065619C00008
EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) ACTIVITY IN MOZAMBIQUE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Agency for International Development |
| Office | USAID/MOZAMBIQUE |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | R408 — Program Management/Support Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $253.9M |
| Current contract value | $326.6M |
| Potential contract value / ceiling | $326.6M |
| Start date | Apr 18, 2019 |
| Current end date | Sep 17, 2028 |
| Potential end date | Sep 17, 2028 |
| Latest award activity | Aug 10, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 40 of 40 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 17, 2026 | P00039 | $-3.5M | EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) ACTIVITY IN MOZAMBIQUE |
| Aug 17, 2026 | P00040 | $3.5M | MODIFICATION TO ADMINISTRATIVELY MOVE FUNDING FROM USAID TO STATE SYSTEMS FOR CONTINUED SUPPORT OF SERVICING AND MANAGEMENT OF USAID AWARD (19AQMM26C0786) |
| Aug 10, 2026 | P00038 | $5.9M | MODIFICATION TO ADMINISTRATIVELY MOVE FUNDING FROM USAID TO STATE SYSTEMS FOR CONTINUED SUPPORT OF SERVICING AND MANAGEMENT OF USAID AWARD (19AQMM26C0786) |
| Apr 28, 2026 | P00036 | $8.5M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND THE AWARD. |
| Mar 23, 2026 | P00035 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND POP BY 29 MONTHS AND INCREASE TEC |
| Jan 7, 2026 | P00034 | $11.7M | ADD INCREMENTAL FUNDING. |
| Aug 20, 2025 | P00033 | $0 | ENSURE COMPLIANCE WITH EXECUTIVE ORDERS (EO) 14173; 14168; 14148; AND 14208. |
| Jul 24, 2025 | P00032 | $0 | EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) - MOZAMBIQUE |
| Jul 3, 2025 | P00031 | $0 | THE PURPOSE OF THIS MEMORANDUM IS TO: 1) PROVIDE INCREMENTAL FUNDING IN THE AMOUNT OF $8,886,245.00 THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT FROM $218,973,713.79 TO $227,859,958.79 TO SUPPORT THE IMPLEMENTATION OF FY26 QUARTER 1 ACTIVITIES 2) |
| Jun 30, 2025 | P00030 | $8.9M | THE PURPOSE OF THIS MEMORANDUM IS TO: 1) PROVIDE INCREMENTAL FUNDING IN THE AMOUNT OF $8,886,245.00 THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT FROM $218,973,713.79 TO $227,859,958.79 TO SUPPORT THE IMPLEMENTATION OF FY26 QUARTER 1 ACTIVITIES; 2) |
| Mar 13, 2025 | P00029 | $18.4M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Sep 24, 2024 | P00028 | $17.1M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Aug 9, 2024 | P00027 | $600.0K | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Jun 14, 2024 | P00026 | $577.8K | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Apr 17, 2024 | P00025 | $0 | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Mar 7, 2024 | P00024 | $10.7M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Dec 5, 2023 | P00023 | $14.5M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Oct 24, 2023 | P00022 | $500.0K | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Sep 20, 2023 | P00021 | $9.8M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Jul 17, 2023 | P00020 | $1.6M | EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) |
| Dec 16, 2022 | P00019 | $19.1M | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUND CONTRACT # 72056519C00008 WITH ECHO PROJECT, MANAGED BY ABT ASSOCIATES, IN THE AMOUNT OF $19,061,320 THEREBY INCREASING THE SUB- OBLIGATED AMOUNT FROM $126,170,772.79 TO $145,232,092.79 TO |
| Sep 22, 2022 | P00018 | $17.0M | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUND CONTRACT # 72056519C00008 WITH ECHO PROJECT, MANAGED BY ABT ASSOCIATES, IN THE AMOUNT OF $17,458,956.72 THEREBY INCREASING THE SUB- OBLIGATED AMOUNT FROM $109,123,316.07 TO $126,582,272.79, |
| Jul 5, 2022 | P00017 | $700.0K | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUND CONTRACT # 72056519C00008 WITH ECHO PROJECT, MANAGED BY ABT ASSOCIATES, IN THE AMOUNT OF $700,000.00 THEREBY INCREASING THE SUB-OBLIGATED AMOUNT FROM $107,173,316.07 TO $107,873,316.07 T |
| Apr 28, 2022 | P00016 | $1.2M | THE AUTHORIZED AGENT IS REQUESTED TO: 1) INCREMENTALLY FUND |
| Mar 8, 2022 | P00015 | $15.2M | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUND THE CONTRACT # 72056519C00008 WITH ECHO ABT-ASSOCIATE IN THE AMOUNT OF $15,241,484.00 THEREBY INCREASING THE TOTAL AMOUNT OBLIGATED FROM $91,931,832.07 TO $107,173,316.07. |
| Feb 11, 2022 | P00014 | $5.0M | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUND CONTRACT # 72056519C00008 WITH ECHO PROJECT, MANAGED BY ABT ASSOCIATES, IN THE AMOUNT OF $400,000 OF HIV COVID RAPID RESPONSE FUNDS (ARPA FUNDS). THIS INCREASES THE SUB- OBLIGATED AMOUNT |
| Nov 29, 2021 | P00013 | $9.4M | THE AUTHORIZED AGENT IS HERE REQUESTED TO DE-SUB-OBLIGATE $450,000 FROM THE HIV ARPA FUNDS. |
| Sep 30, 2021 | P00012 | $0 | THE AUTHORIZED AGENT IS HERE REQUESTED TO DE-SUB-OBLIGATE $450,000 FROM THE HIV ARPA FUNDS. |
| Sep 22, 2021 | P00011 | $9.0M | THE AUTHORIZED AGENT IS REQUESTED TO: (A) PROVIDE INCREMENTAL FUNDING TO CONTRACT # 72056519C00008 WITH THE ECHO PROJECT, ABT ASSOCIATES, IN THE AMOUNT OF $9,000,000. THIS INCREASES THE SUB-OBLIGATED AMOUNT FROM $68,552,668.79 TO $77,552,668. |
| Aug 24, 2021 | P00010 | $540.0K | THE AUTHORIZED AGENT IS REQUESTED TO: - INCREMENTALLY FUN |
| May 4, 2021 | P00009 | $16.0M | THE AUTHORIZED AGENT IS REQUESTED TO: - INCREMENTALLY FUN |
| Dec 16, 2020 | P00008 | $7.0M | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUNDS TO THE CONTRACT # 72056519C00008 WITH ABT-ASSOCIATE IN THE AMOUNT OF $6,962,240 THEREBY INCREASING THE (SUB)OBLIGATED AMOUNT FROM $45,055,585.79 TO $52,017,825.79 TO ALLOW FULL IMPLEMENTATION O |
| Sep 18, 2020 | P00007 | $12.2M | TO UPDATE PRE-GLAAS CHECKLIST |
| Apr 6, 2020 | P00006 | $800.0K | THE AUTHORIZED AGENT IS REQUESTED TO INCREMENTALLY FUNDS TO THE CONTRACT # 72056519C00008 WITH ABT-ASSOCIATE IN THE AMOUNT OF $800,000 THEREBY INCREASING THE (SUB)OBLIGATED AMOUNT FROM $32,067,060.79 TO $32,867,060.79 TO PROVIDE ECHO WITH COVID19 FU |
| Apr 4, 2020 | P00005 | $9.7M | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDS TO THE AWARD AND UPDATE THE B&M PLAN. |
| Feb 20, 2020 | P00004 | $4.0M | PROVIDE INCREMENTAL FUNDING IN THE AMOUNT OF $4,000,000.00, THEREBY INCREASING THE TOTAL OBLIGATED AMOUNT FROM $18,328,483.79 TO $22,328,483.79. |
| Jan 7, 2020 | P00003 | $0 | THE AUTHORIZED AGENT IS REQUESTING TO MODIFY CONTRACT AGREEMENT #72065618R00008 WITH ABT ASSOCIATES, INC. - EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) TO INCREMENTALLY FUNDING THE CONTRACT BY $10,328,483.79 THEREFORE INCREASING THE TO |
| Dec 3, 2019 | P00002 | $10.3M | THE AUTHORIZED AGENT IS REQUESTING TO MODIFY CONTRACT AGREEMENT #72065618R00008 WITH ABT ASSOCIATES, INC. - EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) TO INCREMENTALLY FUNDING THE CONTRACT BY $10,328,483.79 THEREFORE INCREASING THE TO |
| Nov 18, 2019 | P00001 | $0 | THE AUTHORIZED AGENT IS REQUESTING TO MODIFY CONTRACT AGREEMENT #72065618R00008 WITH ABT ASSOCIATES, INC. - EFFICIENCIES FOR CLINICAL HIV/AIDS OUTCOMES (ECHO) TO CHANGE THE REPORTING REQUIREMENTS TO INCLUDE: 1) REPORTING TIME ON CERTAIN INDICATORS T |
| Apr 18, 2019 | 0 | $8.0M | EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) ACTIVITY IN MOZAMBIQUE |
Estimated positioning window
Sep 17, 2027 – Mar 17, 2028
Recompete signal: . Rule-based research score; positioning dates are estimates.
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2028-09-17 (693 days from calculation)
- +25 points
- 1 historical awards in this buyer and category group
- +0 points
- 40 recorded award transactions
- +10 points
- Latest award action: 2026-08-10
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.